Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leander Merritt is active.

Publication


Featured researches published by Leander Merritt.


Bioorganic & Medicinal Chemistry Letters | 1994

Isoarecolones and arecolones: selective central nicotinic agonists that cross the blood-brain barrier

John S. Ward; Leander Merritt; Frank P. Bymaster; David O. Calligaro

Abstract Isoarecolones and arecolones bearing different ketone substituents were synthesized and their affinities at central muscarinic and nicotinic receptors determined. The compounds were selective for nicotinic receptors, produced appropriate nicotinic responses, and crossed the blood brain barrier in rats.


Biochemical and Biophysical Research Communications | 1992

Steric and electronic requirements for muscarinic receptor-stimulated phosphoinositide turnover in the CNS in a series of arecoline bioisosteres

Dan O. Ngur; Scott Roknich; Charles H. Mitch; Steven J. Quimby; John S. Ward; Leander Merritt; Per Sauerberg; William S. Messer; Wayne Hoss

A series of arecoline derivatives was utilized to assess steric and electronic effects important for activating muscarinic receptors in the CNS. Arecoline derivatives in which the methyl ester moiety was replaced by hexyloxy-1,2,5-oxadiazole (2b), hexyloxythiophene (3b) or hexyloxypyrazine (4b) were compared with the hexyloxy-1,2,5-thiadiazole compound (1b) (Hexyloxy-TZTP), known from previous work to be active as an M1/M3 partial agonist. MNDO calculations showed that the N-S bonds of the alkoxythiadiazole ring were highly polarized with the ability to form H-bonds to the Ns. On the other hand, the smaller oxadiazole had lower polarities in the N-O bonds and reduced ability to form H-bonds, the thiophene was of comparable size to the thiadiazole and had large C-S bond polarities without the H-bond capability and the pyrazine had limited ability to form H-bonds. The compounds were compared with respect to their abilities to stimulate phosphoinositide (Pl) turnover in the hippocampus of the rat brain. 1b was more active than 2b-4b for stimulating the Pl turnover response. The data suggest that the ability to form H-bonds is an important factor for the ability of 1 to stimulate M1 muscarinic receptors in the CNS.


Journal of Medicinal Chemistry | 1992

Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.

John S. Ward; Leander Merritt; Valentine J. Klimkowski; Michelle L. Lamb; Charles H. Mitch; Franklin Porter Bymaster; Barry D. Sawyer; Harlan E. Shannon; P. Olesen; Honoré T


Journal of Medicinal Chemistry | 1998

1,2,5-Thiadiazole Analogues of Aceclidine as Potent m1 Muscarinic Agonists

John S. Ward; Leander Merritt; David O. Calligaro; Franklin Porter Bymaster; Harlan E. Shannon; Charles H. Mitch; Celia A. Whitesitt; David Brunsting; Malcolm J. Sheardown; Preben H. Olesen; Michael D. B. Swedberg; Lone Jeppesen; Per Sauerberg


Journal of Medicinal Chemistry | 1995

Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.

J.S. Ward; Leander Merritt; David O. Calligaro; Franklin Porter Bymaster; Harlan E. Shannon; Barry D. Sawyer; C.H. Mitch; Deeter Jb; Steven C. Peters; Malcolm J. Sheardown; Preben H. Olesen; Swedberg; Per Sauerberg


Journal of Heterocyclic Chemistry | 1991

The convergent syntheses of pyrazinyl and quinoxalinyl phenylmethanones from 2-lithio pyrazines and quinoxalines

John S. Ward; Leander Merritt


Archive | 1998

Process for preparing heterocyclic compounds

Leander Merritt; John S. Ward


Journal of Heterocyclic Chemistry | 1990

The improved convergent syntheses of arecolones and isoarecolone

John S. Ward; Leander Merritt


Journal of Medicinal Chemistry | 1988

Ergolines as selective 5-HT1 agonists

John S. Ward; Ray W. Fuller; Leander Merritt; Harold D. Snoddy; Jonathan W. Paschal; Norman R. Mason; J. S. Horng


Archive | 1987

Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement

Leander Merritt; John S. Ward

Collaboration


Dive into the Leander Merritt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge